Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
US Department of Justice
Deloitte
Teva
Accenture
UBS
AstraZeneca
Cipla
Boehringer Ingelheim
Mallinckrodt

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020474

« Back to Dashboard

NDA 020474 describes VEXOL, which is a drug marketed by Alcon and is included in one NDA. It is available from one supplier. Additional details are available on the VEXOL profile page.

The generic ingredient in VEXOL is rimexolone. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the rimexolone profile page.
Summary for 020474
Tradename:VEXOL
Applicant:Alcon
Ingredient:rimexolone
Patents:0
Therapeutic Class:Ophthalmic Agents
Pharmacology for NDA: 020474
Suppliers and Packaging for NDA: 020474
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VEXOL rimexolone SUSPENSION/DROPS;OPHTHALMIC 020474 NDA Alcon Laboratories, Inc 0065-0627 0065-0627-07 5 mL in 1 BOTTLE, PLASTIC (0065-0627-07)
VEXOL rimexolone SUSPENSION/DROPS;OPHTHALMIC 020474 NDA Alcon Laboratories, Inc 0065-0627 0065-0627-03 10 mL in 1 BOTTLE, PLASTIC (0065-0627-03)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SUSPENSION/DROPS;OPHTHALMICStrength1%
Approval Date:Dec 30, 1994TE:RLD:No

Expired US Patents for NDA 020474

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alcon VEXOL rimexolone SUSPENSION/DROPS;OPHTHALMIC 020474-001 Dec 30, 1994 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Queensland Health
Cantor Fitzgerald
Baxter
AstraZeneca
Colorcon
Healthtrust
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot